Cancer in China:
Expanding market access for cancer therapies
A report by The Economist Intelligence Unit
Cancer is a complex disease, and, with increasing incidence and mortality, it is a major public health concern in China. The Chinese government’s 13th Five-Year Healthcare Plan for 2016-20 has prompted The Economist Intelligence Unit to re-evaluate the local cancer care market, which is evolving rapidly amid bold medical reforms. In this paper, we explore the market landscape in China and market-access initiatives of companies offering cancer treatments, to help pharmaceutical companies to understand how to better facilitate early and expanded access to this market.